07:00 , Mar 18, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute myeloid leukemia (AML) MicroRNA-29a (miR-29a) A study in cell culture and in mice suggests that inhibiting miR-29a could help treat AML. In leukemia stem...
07:00 , Jul 9, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease HIV/AIDS MicroRNA-29a (miRNA-29a) Studies in cell culture suggest that targeting miRNA-29a could help treat HIV infection. In human cell lines, an miRNA-29a inhibitor increased...
07:00 , May 8, 2008 |  BC Innovations  |  Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Alzheimer's disease (AD) MicroRNA-29a; miRNA-29b-1; b-secretase (BACE1); amyloid precursor protein (APP) An analysis of cortical tissue from AD patients identified two...